Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.63 |
| ▸ | MEN1 | O00255 | 5/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | GBA1 | P04062 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL694247 | 0.84 | CYP1A1 (0.53) | KMT2AMEN1MAPK1ALDH1A1MAPT | |
| SCHEMBL11763476 | 0.82 | KMT2A (0.59) | KMT2AMEN1HPGDNPC1RAB9A | |
| SCHEMBL1532371 | 0.82 | POLB (0.63) | KMT2AMEN1ALDH1A1MAPTHTT | |
| SCHEMBL572726 | 0.82 | GAA (0.56) | KMT2ANPC1RAB9AALDH1A1MAPT | |
| SCHEMBL4835086 | 0.82 | MEN1 (0.65) | KMT2AMEN1HPGDNPC1RAB9A | |
| SCHEMBL733776 | 0.81 | EPHX2 (0.53) | ALDH1A1MAPTHTTSMN1; SMN2L3MBTL1 | |
| SCHEMBL11347529 | 0.81 | KMT2A (0.43) | KMT2AMEN1HPGDNPC1RAB9A | |
| SCHEMBL7428098 | 0.79 | ALDH1A1 (0.60) | KMT2AMEN1NPC1RAB9AALDH1A1 | |
| SCHEMBL10965290 | 0.79 | MAPT (0.58) | KMT2AMEN1NPC1RAB9AMAPK1 | |
| SCHEMBL1039601 | 0.79 | KMT2A (0.76) | KMT2AMEN1HPGDNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1730102-B1 | A NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3 , 4,4'-TETRAMINOBIPHENYL | COUNCIL SCIENT IND RES (IN) | 2010-09-22 | — | — | EP | claimed |
| EP-1730102-A1 | A NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3 , 4,4'-TETRAMINOBIPHENYL | Council of Scientific and Industrial Research (IN) | 2006-12-13 | — | — | EP | claimed |
| WO-2005092839-A1 | A NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3', 4,4'-TETRAMINOBIPHENYL | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-10-06 | — | — | WO | claimed |
| CN-112341431-A | Heterocyclic compounds as FGFR4 inhibitors | 齐鲁制药有限公司 | 2021-02-09 | — | — | CN | disclosed |
| EP-1730102-B1 | A NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3 , 4,4'-TETRAMINOBIPHENYL | COUNCIL SCIENT IND RES (IN) | 2010-09-22 | — | — | EP | disclosed |
| EP-1730102-A1 | A NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3 , 4,4'-TETRAMINOBIPHENYL | Council of Scientific and Industrial Research (IN) | 2006-12-13 | — | — | EP | disclosed |
| EP-1730102-A1 | A NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3 , 4,4'-TETRAMINOBIPHENYL | Council of Scientific and Industrial Research (IN) | 2006-12-13 | — | — | EP | disclosed |
| US-6979749-B2 | Catalytic process for the production of 3,3′, 4,4′-tetraminobiphenyl | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-12-27 | — | — | US | disclosed |
| WO-2005092839-A1 | A NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3', 4,4'-TETRAMINOBIPHENYL | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-10-06 | — | — | WO | disclosed |
| WO-2005092839-A1 | A NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3', 4,4'-TETRAMINOBIPHENYL | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-10-06 | — | — | WO | disclosed |
| US-20050215823-A1 | NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3', 4,4'-TETRAMINOBIPHENYL | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-09-29 | — | — | US | disclosed |
| US-20050215823-A1 | NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3', 4,4'-TETRAMINOBIPHENYL | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-09-29 | — | — | US | disclosed |
| EP-0299452-B1 | Polyquinoxaline polymers, and articles comprising same | AT & T CORP (US) | 1994-10-05 | — | — | EP | disclosed |
| US-4914177-A | Polyquinoxaline polymers, and articles comprising same | AMERICAN TELEPHONE AND TELEGRAPH COMPANY (US) | 1990-04-03 | — | — | US | disclosed |
| EP-0299452-A2 | Polyquinoxaline polymers, and articles comprising same | AT&T Corp. (US) | 1989-01-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050215823-A1 | NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3', 4,4'-TETRAMINOBIPHENYL | NNMT, CBR3, POR | KMT2A 130/4885MEN1 2108/4885HPGD 1008/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.